The Canadian National Immunization Advisory Committee recommended on the 17th that those who receive the AstraZeneca COVID-19 vaccine will have the "priority" of Pfizer or Moderna vaccines for the second dose.

html On June 18, a woman left the COVID-19 vaccination center in New Westminster, Canada.

Canada's National Immunization Advisory Committee recommended on the 17th that for those who receive the AstraZeneca COVID-19 vaccine, the second dose can be "prioritized" to choose Pfizer or Moderna vaccine. As of June 5, more than 2.1 million people in Canada received one dose of AstraZeneca vaccine , and 15,186 people received two doses. At present, there are still about 600,000 doses of AstraZeneca vaccine in Canada that have not been used. Xinhua News Agency (photo by Liang Sen)

html On June 18, people were waiting in line outside a new crown vaccination center in New Westminster, Canada.

Canada's National Immunization Advisory Committee recommended on the 17th that those who receive the first dose of AstraZeneca's new crown vaccine can "priority" choose Pfizer or Moderna vaccine for the second dose. As of June 5, more than 2.1 million people in Canada received one dose of AstraZeneca vaccine and 15,186 people received two doses. At present, there are still about 600,000 doses of AstraZeneca vaccine in Canada that have not been used. Xinhua News Agency (photo by Liang Sen)

htmlOn June 18, people were waiting in line outside a new crown vaccination center in New Westminster, Canada.

Canada's National Immunization Advisory Committee recommended on the 17th that those who receive the first dose of AstraZeneca's new crown vaccine can "priority" choose Pfizer or Moderna vaccine for the second dose. As of June 5, more than 2.1 million people in Canada received one dose of AstraZeneca vaccine and 15,186 people received two doses. At present, there are still about 600,000 doses of AstraZeneca vaccine in Canada that have not been used. Xinhua News Agency (photo by Liang Sen)